Clinical trial
Do Mutations in the Filaggrin Gene Have Clinical Importance for the Treatment Outcome in Atopic Dermatitis?
NCT01689805 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Do Mutations in the Filaggrin Gene Have Clinical Importance for the Treatment Outcome in Atopic Dermatitis?
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2011
- Completion date
- Not reported
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis